Literature DB >> 24145685

Walking Index for Spinal Cord Injury version II in acute spinal cord injury: reliability and reproducibility.

G Scivoletto1, F Tamburella1, L Laurenza2, M Torre2, M Molinari1, J F Ditunno3.   

Abstract

STUDY
DESIGN: Administration of the walking index for SCI (WISCI) II is recommended to assess walking in spinal cord injury (SCI) patients. Determining the reliability and reproducibility of the WISCI II in acute SCI would be invaluable.
OBJECTIVES: The objective of this study is to assess the reliability and reproducibility of the WISCI II in patients with traumatic, acute SCI.
DESIGN: Test-retest analysis and calculation of reliability and smallest real difference (SRD).
SETTING: SCI unit of a rehabilitation hospital.
METHODS: Thirty-three patients, median age 44 years, median time since onset of SCI 40 days. Level: 20 cervical, 8 thoracic, 5 lumbar; ASIA (American Spinal Injury Association) impairment scale (AIS) grade: 32 D/1 C. Assessment of maximum WISCI II levels by two trained, blinded raters to evaluate interrater (IRR) and intrarater reliability.
RESULTS: The intrarater reliability was 0.999 for therapists A and 0.979 for therapists B, for the maximum WISCI II level. The IRR for the maximum WISCI II score was 0.996 on day 1 and 0.975 on day 2. The SRD for the maximum WISCI II score was 1.147 for tetraplegics and 1.682 for paraplegics. These results suggest that a change of two WISCI II levels could be considered real.
CONCLUSIONS: The WISCI II has high IRR and intrarater reliability and good reproducibility in the acute and subacute phase when administered by trained raters.

Entities:  

Mesh:

Year:  2013        PMID: 24145685     DOI: 10.1038/sc.2013.127

Source DB:  PubMed          Journal:  Spinal Cord        ISSN: 1362-4393            Impact factor:   2.772


  9 in total

1.  The voluntary driven exoskeleton Hybrid Assistive Limb (HAL) for postoperative training of thoracic ossification of the posterior longitudinal ligament: a case report.

Authors:  Kengo Fujii; Tetsuya Abe; Shigeki Kubota; Aiki Marushima; Hiroaki Kawamoto; Tomoyuki Ueno; Akira Matsushita; Kei Nakai; Kosaku Saotome; Hideki Kadone; Ayumu Endo; Ayumu Haginoya; Yasushi Hada; Akira Matsumura; Yoshiyuki Sankai; Masashi Yamazaki
Journal:  J Spinal Cord Med       Date:  2016-02-09       Impact factor: 1.985

2.  The Hybrid Assistive Limb® intervention for a postoperative patient with spinal dural arteriovenous fistula and chronic spinal cord injury: A case study.

Authors:  Yukiyo Shimizu; Kei Nakai; Hideki Kadone; Shunsuke Yamauchi; Shigeki Kubota; Tomoyuki Ueno; Aiki Marushima; Kayo Hiruta; Ayumu Endo; Hiroaki Kawamoto; Akira Matsumura; Yoshiyuki Sankai; Yasushi Hada; Masashi Yamazaki
Journal:  J Spinal Cord Med       Date:  2017-05-29       Impact factor: 1.985

3.  Long-term clinical observation of patients with acute and chronic complete spinal cord injury after transplantation of NeuroRegen scaffold.

Authors:  Fengwu Tang; Jiaguang Tang; Yannan Zhao; Jiaojiao Zhang; Zhifeng Xiao; Bing Chen; Guang Han; Na Yin; Xianfeng Jiang; Changyu Zhao; Shixiang Cheng; Ziqiang Wang; Yumei Chen; Qiaoling Chen; Keran Song; Zhiwei Zhang; Junjie Niu; Lingjun Wang; Qin Shi; Liang Chen; Huilin Yang; Shuxun Hou; Sai Zhang; Jianwu Dai
Journal:  Sci China Life Sci       Date:  2021-08-16       Impact factor: 6.038

4.  Hybrid assistive limb (HAL) treatment for patients with severe thoracic myelopathy due to ossification of the posterior longitudinal ligament (OPLL) in the postoperative acute/subacute phase: A clinical trial.

Authors:  Shigeki Kubota; Tetsuya Abe; Hideki Kadone; Yukiyo Shimizu; Toru Funayama; Hiroki Watanabe; Aiki Marushima; Masao Koda; Yasushi Hada; Yoshiyuki Sankai; Masashi Yamazaki
Journal:  J Spinal Cord Med       Date:  2018-10-18       Impact factor: 1.985

5.  Ambulation following spinal cord injury and its correlates.

Authors:  Nitin Menon; Anupam Gupta; Meeka Khanna; Arun B Taly
Journal:  Ann Indian Acad Neurol       Date:  2015 Apr-Jun       Impact factor: 1.383

6.  Functional Outcome of Neurologic-Controlled HAL-Exoskeletal Neurorehabilitation in Chronic Spinal Cord Injury: A Pilot With One Year Treatment and Variable Treatment Frequency.

Authors:  Oliver Jansen; Thomas A Schildhauer; Renate C Meindl; Martin Tegenthoff; Peter Schwenkreis; Matthias Sczesny-Kaiser; Dennis Grasmücke; Christian Fisahn; Mirko Aach
Journal:  Global Spine J       Date:  2017-07-07

7.  Significant Improvement of Acute Complete Spinal Cord Injury Patients Diagnosed by a Combined Criteria Implanted with NeuroRegen Scaffolds and Mesenchymal Stem Cells.

Authors:  Zhifeng Xiao; Fengwu Tang; Yannan Zhao; Guang Han; Na Yin; Xing Li; Bing Chen; Sufang Han; Xianfeng Jiang; Chen Yun; Changyu Zhao; Shixiang Cheng; Sai Zhang; Jianwu Dai
Journal:  Cell Transplant       Date:  2018-06-05       Impact factor: 4.064

8.  Application of the Gait Deviation Index to Study Gait Impairment in Adult Population With Spinal Cord Injury: Comparison With the Walking Index for Spinal Cord Injury Levels.

Authors:  Isabel Sinovas-Alonso; Diana Herrera-Valenzuela; Roberto Cano-de-la-Cuerda; Ana de Los Reyes-Guzmán; Antonio J Del-Ama; Ángel Gil-Agudo
Journal:  Front Hum Neurosci       Date:  2022-04-04       Impact factor: 3.473

9.  Hybrid Assistive Limb Functional Treatment for a Patient with Chronic Incomplete Cervical Spinal Cord Injury.

Authors:  Yuichiro Soma; Shigeki Kubota; Hideki Kadone; Yukiyo Shimizu; Hiroshi Takahashi; Yasushi Hada; Masao Koda; Yoshiyuki Sankai; Masashi Yamazaki
Journal:  Int Med Case Rep J       Date:  2021-06-21
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.